This page will be regularly updated with information on how the University and Charlottesville community is responding to COVID-19, the illness caused by the novel coronavirus. The Cavalier Daily is committed to thoroughly reporting on its effects and implications for everyone in our community.
Follow the total number of confirmed cases within the Virginia here and read about the University's Spring 2021 plan here.
In comparing Fluvoxamine with a placebo, researchers found that of the 80 participants that received Fluvoxamine, none of them became seriously ill during the trial. Of the patients that received the placebo, six patients became seriously ill and four were hospitalized.
While for some students this option allowed them to breathe a sigh of relief, for pre-med students who will be applying to medical school after graduation, the decision to opt-in to these grading options inherently involves them weighing multiple factors, including future admissions cycles.
Starting Dec. 15, health officials have started administering COVID-19 to workers in the University Health System with 1,594 individuals being vaccinated within the first week and 4,000 individuals signed up for vaccination appointments.
While students will not be subject to disciplinary action for disclosing information during contact tracing or having a positive test result, students who fail to participate in testing will be subject to various sanctions.
The executive order comes as a direct response to COVID-19 case numbers three times those at Virginia’s last peak in May — with an average of 3,700 new cases every day. The order cited an 83 percent increase in hospitalization, and a concerning rate of ICU occupancy.
For 131 years, The Cavalier Daily has served as the first draft of history for the University of Virginia and Charlottesville communities.
As an independent, non-profit student newsroom that receives no money from the University, we rely on contributions from readers like you. Join us in our mission of providing local news and creating opportunities for the next generation of journalists.